Found 15 matching trials
Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension
PHASE2This clinical trial is a study to evaluate the safety, tolerability, and ch...
Location
Radboud University Medical Center
Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)
PHASE2This is a study to evaluate the safety and efficacy of Losmapimod in treati...
Location
University of California Irvine
Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen.
PHASE2The main purpose of this study is to determine the effect of Losmapimod on ...
Location
Cambridge University Hospitals NHS Foundation Trust
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)
PHASE3This is a study to evaluate the safety and efficacy of losmapimod in treati...
Location
University of California Irvine
Losmapimod Safety and Efficacy in COVID-19
PHASE3The therapeutic hypothesis for the use of losmapimod in COVID-19 disease is...
Location
University of California Irvine - Irvine Medical Center
A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging
PHASE2This study is being conducted to assess the potential anti-inflammatory eff...
Location
GSK Investigational Site
Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)
PHASE2This is a randomised, double-blind, parallel-group, multi-centre study eval...
Location
GSK Investigational Site
A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin
PHASE1This will be a double-blind, 4-period, randomized, cross-over study conduct...
Location
GSK Investigational Site
PK Study of IV Formulation of GW856553
PHASE1The purpose of this study is to evaluate the safety of an IV infusion of GW...
Location
GSK Investigational Site
Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
PHASE2This study is an open-label extension to evaluate the safety and tolerabili...
Location
University of California Irvine